Limited 3D printing material options. There are a limited number of materials that can be used in 3D printing. Therefore, one of the main limiting factors is printing speed. Even the construction rates of major 3D printers are slower than those of products manufactured using traditional manufacturing.
For pharmaceutical companies planning to venture into 3D printing, they must develop a policy to certify their plans. Liability risk for defective products Common sense tells us that if a pharmaceutical company licenses its model to pharmacies or healthcare providers to print drugs locally, it is not possible to monitor the effectiveness of all 3D printing operations. Importantly, 3D printing manufacturers must diligently investigate their suppliers, as contaminated or defective materials can produce a defective product and pose an even greater threat than the printers themselves. Cyber risk The proliferation of counterfeit drugs is perhaps the industry's biggest concern in relation to 3D printing.
A 3D printer for medicines on-site in a hospital can make printing easier for your patients when needed. In addition, appropriate security measures, such as the regulation of 3D printer manufacturing, will reduce risks for both patients and medical organizations. For a company considering investing in the future with 3D printing, understanding risk exposures should be one of the first steps in determining if it is a worthwhile investment. However, for pharmaceutical companies that are considering 3D printing in the future, understanding the drawbacks listed above should be the priority.
However, the use and abuse of 3D-printed drugs has also been the subject of debate today. Most, like the plastics used for a new set of teeth, must be ground into small particles for the printer. To keep up to date on the latest developments in the world of 3D printing, follow us on Facebook or follow us on LinkedIn and Twitter. In addition to the benefits mentioned above, the disadvantages of 3D printing in this industry should also be considered.
Pharmaceutical companies that venture into 3D printing should develop a strategy to license their plans to ensure that they are protected financially and legally. These nightmarish situations and more can be applied to health organizations that print their own medical devices, such as syringes, on human tissue, such as ligaments and tendons. Additive manufacturing, better known as 3D printing, has advanced enough to create toys, figures and parts for more complex machines. If the procedure is to be performed on the arm, surgeons can design the component and expand its size to allow visibility of all the veins and vessels found there and then print the prototype.
